Edition:
United States

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

7.70USD
4:00pm EDT
Change (% chg)

$-0.22 (-2.78%)
Prev Close
$7.92
Open
$7.92
Day's High
$8.13
Day's Low
$7.66
Volume
128,933
Avg. Vol
46,332
52-wk High
$17.33
52-wk Low
$6.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 4.61 -0.683
Mar '18 3.97 -0.687
FY 2017 Dec '17 3.06 -0.714
Sep '17 23.01 -0.171
Jun '17 3.01 -0.694
Mar '17 3.02 -0.631
FY 2016 Dec '16 3.04 -0.626
Sep '16 13.02 -0.464
Jun '16 3.00 -0.705
Mar '16 0.00 -1.308
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 7 12.31 23.43 0.00 18.00
Quarter Ending Dec-18 7 6.87 20.17 0.00 3.00
Year Ending Dec-18 7 27.47 35.44 8.58 13.08
Year Ending Dec-19 6 24.54 67.33 8.75 35.04
Earnings (per share)
Quarter Ending Sep-18 7 -0.50 -0.23 -0.78 -0.61
Quarter Ending Dec-18 7 -0.61 -0.33 -0.86 -1.01
Year Ending Dec-18 7 -2.48 -2.23 -2.87 -2.88
Year Ending Dec-19 6 -2.57 -2.14 -3.28 -2.48
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 109.17 32.55
P/E High - Last 5 Yrs. -- 280.12 47.13
P/E Low - Last 5 Yrs. -- 98.84 24.86
Beta -- 0.61 0.87
Price to Sales (TTM) 9.32 110.45 6.32
Price to Book (MRQ) -- 12.64 3.96
Price to Tangible Book (MRQ) -- 19.10 6.00
Price to Cash Flow (TTM) -- 63.46 22.84
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.60 -5.90
Payout Ratio(TTM) -- 5.94 46.65

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 53.02 175.06 8.33
Sales (TTM) vs TTM 1 Yr. Ago 56.95 95.32 6.69
Sales - 5 Yr. Growth Rate -- 24.62 7.54
EPS (MRQ) vs Qtr. 1 Yr. Ago 1.48 282.02 25.23
EPS (TTM) vs TTM 1 Yr. Ago 6.60 -- --
EPS - 5 Yr. Growth Rate -- 23.81 7.60
Capital Spending - 5 Yr. Growth Rate 74.14 38.47 8.36

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.21
Current Ratio (MRQ) 2.76 5.52 2.98
LT Debt to Equity (MRQ) -- 15.14 11.20
Total Debt to Equity (MRQ) -- 18.66 14.01
Interest Coverage (TTM) -- -209.98 34.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.96 54.70
Gross Margin - 5 Yr. Avg. -- 52.62 53.20
EBITD Margin (TTM) -247.67 -- --
EBITD - 5 Yr. Avg -459.95 -178.18 15.84
Operating Margin (TTM) -269.78 -606.83 3.87
Operating Margin - 5 Yr. Avg. -483.10 -191.65 10.99
Pre-Tax Margin (TTM) -264.31 -603.48 4.20
Pre-Tax Margin - 5 Yr. Avg. -479.99 -194.31 11.19
Net Profit Margin (TTM) -264.31 -598.39 0.91
Net Profit Margin - 5 Yr. Avg. -479.99 -191.85 7.51
Effective Tax Rate (TTM) -- 11.63 20.56
Effective Tax Rate - 5 Yr. Avg. -- 19.21 24.33

Efficiency

  Company industry sector
Revenue/Employee (TTM) 251,116 5,345,588 725,212,627
Net Income/Employee (TTM) -663,725 -5,897,254 83,818,761
Receivable Turnover (TTM) -- 4.23 5.04
Inventory Turnover (TTM) -- 2.07 3.63
Asset Turnover (TTM) 0.20 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.45 0.80 9.83
Return on Assets - 5 Yr. Avg. -- 2.68 10.96
Return on Investment (TTM) -63.86 1.47 12.80
Return on Investment - 5 Yr. Avg. -- 2.23 14.08
Return on Equity (TTM) -245.32 0.22 14.92
Return on Equity - 5 Yr. Avg. -- -2.55 15.41
  1 Year 3 Year 5 Year
Sales % 47.48 -- --
EPS (TTM) % 3.86 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Seres Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.46 -3.22 46 66
13 Week -14.38 -20.31 33 67
26 Week -3.06 -11.72 52 45
52 Week -52.72 -59.47 17 87
YTD -21.89 -28.47 34 82
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.31%
# of Holders: 122
Total Shares Held: 31,947,904
3 Mo. Net Change: -548,071
# New Positions: 12
# Closed Positions: 16
# Increased Positions: 50
# Reduced Positions: 45
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.